Evidence map›Paper›PMID 32671518›Full record

ArticleThe protein journal2020

Immobilization of Cellulase onto Core-Shell Magnetic Gold Nanoparticles Functionalized by Aspartic Acid and Determination of its Activity.

Elahe Poorakbar, Ali Akbar Saboury, Behzad Laame Rad, Kamyar Khoshnevisan

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Enzymes for Biomass Pretreatment: A Comprehensive Review.Advances in biochemical engineering/biotechnology · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Elahe PoorakbarDepartment of Biology, Faculty of Sciences, Payame Noor University, Tehran, Iran.
Ali Akbar SabouryInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. saboury@ut.ac.ir.ORCID 0000-0003-0604-9465
Behzad Laame RadDepartment of Biology, Faculty of Sciences, Payame Noor University, Tehran, Iran.
Kamyar KhoshnevisanBiosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
University of Tehran · IRPayame Noor University · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New support was fabricated to enhance the enzyme activity of cellulase following immobilization. Functionalized core-shell magnetic gold nanoparticles were prepared and characterized by X-ray diffraction (XRD), vibrating sample magnetometer (VSM), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Cellulase enzyme was immobilized on support via covalent bonding. The successful binding of the enzyme was chemically confirmed by Fourier-transform infrared spectroscopy (FTIR). The binding efficiency was 84% determined by Bradford assay. Filter Paper Activity (FPase) method was used to measure the enzyme activity at different temperatures (35-75 °C) and pH (2-8). The immobilized cellulase maintained 73% of its initial catalytic activity after 9 h and its activity is 0.78 mmol.ml

Indexed as

Aspartic AcidCellulaseEnzymes, ImmobilizedEnzyme StabilityFungal ProteinsGoldHot TemperatureHydrogen-Ion ConcentrationMagnetite NanoparticlesTalaromycesAspartic AcidCellulaseEnzymes, ImmobilizedFungal ProteinsGoldMagnetite NanoparticlesCellulaseCore-shell magnetic nanoparticlesEnzyme activityImmobilization

Identifiers

PMID32671518
OpenAlexW3043730444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.